CNBX Pharmaceuticals Inc.
CNBX· OTC
CNBXCNBX Pharmaceuticals Inc.
Filed Apr 1, 2014 · 10-Q · 32 days after period end · 0001303681-14-000026
| Metric | Q2 2013 | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|---|
| Net Income | -$32.19K | -$4.64K | -$1.85K | $2.98K |
| EPS Diluted | $0.00 | -$0.01 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CNBX Pharmaceuticals Inc. · CIK 1343009 · Engraved from SEC EDGAR
ended Feb 28, 2014 · filed Apr 1, 2014 · 32 d after period end
